ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Calico Labs, the mysterious Google-backed biotech firm studying age-related diseases, has signed another deal, this one with the University of California, San Francisco, for technology discovered by Peter Walter, a professor of biochemistry and biophysics at the school. For an undisclosed payment, Calico will license technology for small-molecule modulators of the integrated stress response, a set of cellular processes that may contribute to memory decline. Calico also has deals with QB3, a University of California institute; AbbVie; and the Broad Institute of MIT & Harvard.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter